Page last updated: 2024-12-05
2,4-difluoroaniline
Description
2,4-difluoroaniline: chemical intermediate manufactured by the Halex process; RN given refers to parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 9709 |
CHEMBL ID | 1423658 |
SCHEMBL ID | 11425 |
MeSH ID | M0127881 |
Synonyms (65)
Synonym |
BIDD:GT0098 |
benzenamine, 2,4-difluoro- |
SDCCGMLS-0066219.P001 |
ccris 4621 |
brn 2802556 |
einecs 206-687-5 |
nsc 10297 |
ai3-52650 |
aniline, 2,4-difluoro- |
2,4-difluorobenzenamine |
aniline,4-difluoro- |
367-25-9 |
nsc-10297 |
2,4-difluroaniline |
2,4-difluoroaniline |
benzenamine,4-difluoro- |
nsc10297 |
NCGC00091684-01 |
2,4-difluoroaniline, 99% |
AC-10532 |
2,4-difluorophenylamine |
76563-56-9 |
inchi=1/c6h5f2n/c7-4-1-2-6(9)5(8)3-4/h1-3h,9h2 |
cepcpxllfxpzgw-uhfffaoysa- |
D1508 |
AKOS000119718 |
A25254 |
2,4-difluoro-anilin;aniline, 2,4-difluoro-;benzenamine, 2,4-difluoro- |
NCGC00091684-02 |
unii-40p93l7kwd |
4-12-00-01112 (beilstein handbook reference) |
40p93l7kwd , |
ec 206-687-5 |
tox21_200620 |
dtxcid905064 |
dtxsid6025064 , |
NCGC00258174-01 |
cas-367-25-9 |
2,4-difluoro-phenylamine |
FT-0601172 |
AM20040294 |
STL264190 |
SCHEMBL11425 |
difluoroaniline, 2,4- |
2,4-difluoroaniline [mi] |
2,4difluoroaniline |
2,4-difluoro aniline |
2, 4-difluoroaniline |
2,4 -difluoroaniline |
2,4-di-fluoroaniline |
2,4-difluoro-aniline |
2,4 difluoro aniline |
2.4-difluoroaniline |
(2,4-difluorophenyl)amine |
W-106593 |
CHEMBL1423658 |
CS-W020027 |
PS-9155 |
mfcd00007648 |
F2182-0028 |
n-boc-3-methylnipecoticacidethylester |
CCG-302504 |
Q27258348 |
EN300-19930 |
Z104476120 |
Research Excerpts
Toxicity
Excerpt | Reference | Relevance |
" However, by-products of disinfection may exert toxic effects." | ( Subacute toxicity assessment of water disinfection byproducts on zebrafish. Baska, F; Csenki, Z; Gustafson, R; Hegyi, A; Kis, R; Kovács, R; Rácz, G; Sujbert, L; Szende, B; Urbányi, B; Zsákovics, I, 2012) | 0.38 |
Dosage Studied
Protein Targets (4)
Potency Measurements
Biological Processes (13)
Molecular Functions (10)
Ceullar Components (4)
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 32.50
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 32.50 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.42 (4.65) | Search Engine Demand Index | 36.32 (26.88) | Search Engine Supply Index | 2.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |